NCT02785159

Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis

A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion With Tazorac (Tazarotene) Cream, 0.05% in the Treatment of Plaque Psoriasis

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 152 (actual)
• Sponsor: Bausch Health Americas, Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis

Detailed description

A Phase 2, Multicenter, Double-Blinded, Randomized, Vehicle-Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion with Tazorac (tazarotene) Cream, 0.05% in the Treatment of Plaque Psoriasis

Conditions

• Psoriasis

Interventions

Type	Name	Description
DRUG	IDP-118 Lotion	Lotion
DRUG	Tazorac Cream	Cream
DRUG	IDP-118 Vehicle Lotion	Lotion
DRUG	IDP-118 Vehicle Cream	Cream

Timeline

• Start date: 2016-02-01
• Primary completion: 2016-11-20
• Completion: 2016-12-01
• First posted: 2016-05-27
• Last updated: 2020-08-20
• Results posted: 2020-08-20

Locations

14 sites across 1 country: United States